I agree that this site is using cookies. You can find further informations here.
X
Oda, Kazutaka
106  results:
Search for persons X
?
1

Validation and development of population pharmacokinetic mo..:

Oda, Kazutaka ; Matsumoto, Kazuaki ; Shoji, Kensuke...
Journal of Infection and Chemotherapy.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

A simulation study on model‐informed precision dosing of am..:

Yamada, Tomoyuki ; Oda, Kazutaka ; Nishihara, Masami.
British Journal of Clinical Pharmacology.  90 (2024)  4 - p. 1173-1182 , 2024
Link: https://doi.org/10.1111/..
 
?
3

Effect of concomitant use of yokukansan on steady‐state blo..:

Saruwatari, Junji ; Kaneko, Tetsuya ; Murata, Tsukasa...
Neuropsychopharmacology Reports.  , 2024
Link: https://doi.org/10.1002/..
 
?
4

Relationship between Target Time above Minimum Inhibitory C..:

Nakashima, Hajime ; Miyazaki, Motoyasu ; Kuwamura, Tsuneo...
Antibiotics.  13 (2024)  3 - p. 219 , 2024
Link: https://doi.org/10.3390/..
 
?
5

Thiamylal serum concentration for refractory convulsive sta..:

Oda, Kazutaka ; Katanoda, Tomomi ; Arakaki, Hitomi...
Journal of Pharmaceutical Health Care and Sciences.  10 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

A cohort study of the risk factors and the target AUC to av..:

Kanazawa, Naoko ; Shigemi, Akari ; Amadatsu, Nao...
Journal of Infection and Chemotherapy.  30 (2024)  4 - p. 323-328 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Population Pharmacokinetics and AUC-Guided Dosing of Tobram..:

Hashiguchi, Yumi ; Matsumoto, Naoya ; Oda, Kazutaka..
Clinical Therapeutics.  45 (2023)  5 - p. 400-414.e2 , 2023
Link: https://doi.org/10.1016/..
 
?
8

Model‐informed precision dosing of vancomycin for rapid ach..:

Oda, Kazutaka ; Yamada, Tomoyuki ; Matsumoto, Kazuaki...
Clinical and Translational Science.  16 (2023)  11 - p. 2265-2275 , 2023
Link: https://doi.org/10.1111/..
 
?
9

Model‐informed precision dosing of teicoplanin for the rapi..:

Oda, Kazutaka ; Yamada, Tomoyuki ; Matsumoto, Kazuaki...
Clinical and Translational Science.  16 (2023)  4 - p. 704-713 , 2023
Link: https://doi.org/10.1111/..
 
?
10

Optimal timing for therapeutic drug monitoring of voriconaz..:

Hanai, Yuki ; Ueda, Takashi ; Hamada, Yukihiro...
Mycoses.  66 (2023)  12 - p. 1035-1044 , 2023
Link: https://doi.org/10.1111/..
 
?
11

Bayesian prediction-based individualized dosing of anti-met..:

Oda, Kazutaka ; Saito, Hideyuki ; Jono, Hirofumi
Pharmacology & Therapeutics.  246 (2023)  - p. 108433 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Prophylactic effect of tixagevimab–cilgavimab on COVID-19 i..:

Tatetsu, Hiro ; Higuchi, Yusuke ; Shichijo, Takafumi...
International Journal of Hematology.  118 (2023)  2 - p. 303-305 , 2023
Link: https://doi.org/10.1007/..
 
?
13

Clinical Practice Guideline for the Therapeutic Drug Monito..:

Takesue, Yoshio ; Hanai, Yuki ; Oda, Kazutaka...
Clinical Therapeutics.  44 (2022)  12 - p. 1604-1623 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Clinical Practice Guidelines for Therapeutic Drug Monitorin..:

Matsumoto, Kazuaki ; Oda, Kazutaka ; Shoji, Kensuke...
Pharmaceutics.  14 (2022)  3 - p. 489 , 2022
Link: https://doi.org/10.3390/..
 
?
15

Validation of Vancomycin Area under the Concentration—Time ..:

Ueda, Takashi ; Takesue, Yoshio ; Nakajima, Kazuhiko...
Antibiotics.  11 (2022)  1 - p. 96 , 2022
Link: https://doi.org/10.3390/..
 
1-15